[go: up one dir, main page]

JP4320157B2 - Ultrasonic device - Google Patents

Ultrasonic device Download PDF

Info

Publication number
JP4320157B2
JP4320157B2 JP2002320789A JP2002320789A JP4320157B2 JP 4320157 B2 JP4320157 B2 JP 4320157B2 JP 2002320789 A JP2002320789 A JP 2002320789A JP 2002320789 A JP2002320789 A JP 2002320789A JP 4320157 B2 JP4320157 B2 JP 4320157B2
Authority
JP
Japan
Prior art keywords
ultrasonic
transmission
skull
frequency
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002320789A
Other languages
Japanese (ja)
Other versions
JP2004154205A (en
Inventor
隆 東
晋一郎 梅村
博 古幡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Hitachi Healthcare Manufacturing Ltd
Original Assignee
Hitachi Ltd
Hitachi Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Ltd, Hitachi Medical Corp filed Critical Hitachi Ltd
Priority to JP2002320789A priority Critical patent/JP4320157B2/en
Publication of JP2004154205A publication Critical patent/JP2004154205A/en
Application granted granted Critical
Publication of JP4320157B2 publication Critical patent/JP4320157B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Clinical applications
    • A61B8/0808Clinical applications for diagnosis of the brain

Landscapes

  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、超音波を用いて被検体の画像を撮像する超音波撮像装置及び超音波を用いた血栓溶解装置等を含む超音波装置に関する。
【0002】
【従来の技術】
経頭蓋骨超音波ドップラ計測は、簡便に脳内血流を観測する手段として、既に確立している。また、tPA(tissue plasminogen activator)を用いた血栓溶解治療時に経頭蓋骨超音波ドップラ計測を行うと、血栓溶解効果が高まることが提案されている(例えば、非特許文献1参照)。このドップラ計測用の超音波は、分解能と減衰を勘案して、2MHz程度の周波数が用いられている。
【0003】
超音波の印加による血栓の溶解促進効果に関しては、500kHz程度の周波数がキャビテーションや温度上昇の効果から望ましいとされている(例えば、非特許文献2参照)。
【0004】
しかし、上記のように、治療用には500kHz程度の比較的低い周波数、ドップラ計測用には2MHz程度の比較的高い周波数を用いるには、両者のトランスデューサを別々に備えるか(例えば、特許文献1、特許文献2参照)、もしくは、モニタリング用超音波の周波数を治療用超音波の周波数の奇数倍にすることで、一つのトランスデューサで二役をこなす必要がある(例えば、特許文献3参照)。
【0005】
【非特許文献1】
A.V.Alexander, et al.,“High Rate Complete Recanalization and Dramatic Clinical Recovery During tPA Infusion When Continuous ly Monitored With 2-MHz Transcranial Doppler Monitoring”, Str oke,2002, vol.31, p.610-614
【非特許文献2】
T. Ishibashi, et al.,“Can Transcranial Ultrasonication Increa se Recanalization Flow With Tissue Plasminogen Activator?”、 Stroke,2002, vol. 33, p.1399-1404
【特許文献1】
特開平5−220152号公報
【特許文献2】
特開2001−327495号公報
【特許文献3】
特開平6−269448号公報
【0006】
【発明が解決しようとする課題】
図1は、超音波の送受波を行なう頭蓋骨のこめかみ周辺の断面と、頭蓋骨に対する超音波トランスデューサ(超音波送受波器)1の素子列を示す図である。頭蓋骨20は、殆どの部分が図1の両側に示すように、穴の空いた板間層21を間に挟む構造になっており、この板間層21の部分は超音波の減衰が大きいことが知られている。一方、こめかみの部分は、板間層21が無い、もしくは、非常に薄いため、板間層21の有る部分に比べ超音波の減衰が少ないことが知られており、頭蓋骨内を超音波で撮像もしくは治療する場合の、音響的な窓として利用されている。
【0007】
しかし、超音波を比較的良く通す、上記の音響的な窓の領域の大きさは、数cm四方と限られているため、この狭い領域で、モニタリング用と治療用に別々のトランスデューサを並べて用いることは困難であるとういう課題を有する。
【0008】
一方、一つのトランスデューサで、モニタリング用と治療用の二役をこなすのは、トランスデューサの振動が、実際には、厚み共振以外に横のモードとカップリングして振動することや、音響整合層のことも考慮にいれると、二つの周波数に対して最適化する設計は、極めて困難であるという課題を有する。
【0009】
本発明の目的は、経頭蓋骨超音波ドップラによるモニタリングにおける超音波照射と、tPAの血栓溶解効果を促進する超音波照射とにおいて、同じ周波数帯域の超音波を使うこと可能とする超音波装置を提供することにあり、超音波血流モニタリングの下で超音波照射によるtPAの血栓溶解効果の増強をもたらすことが可能な超音波装置を提供することにある。
【0010】
【課題を解決するための手段】
上記目的を達成するために、本発明では、被検体に超音波を送受波する送受波器と、送受波器を構成する複数の電気超音波変換素子(以下、素子)と送受波器に接続する送波ビームフォーマ及び受波ビームフォーマを備え、血流像の画像化が可能な超音波装置(経頭蓋骨超音波撮像装置)であって、超音波パルスを送受信することで頭蓋骨の厚み分布を計測する手段を備え、この厚み分布に基づいて、素子毎に透過率が最大となる送信周波数を選択する手段を備え、血栓溶解用薬剤の超音波による効果増強を最適化する。
【0011】
本発明の超音波装置は、複数の電気超音波変換素子からなり、被検体に対して、超音波パルスを送受信する超音波送受波器と、素子に対し超音波の送信と受信を切りかえる送受波切替スイッチと、送受波切替スイッチに接続し、被検体内での超音波の送信焦点位置を制御する送波ビームフォーマと、被検体内の受信焦点位置を制御する受波ビームフォーマと、受波ビームフォーマの出力を入力とする検波器と検波器の出力から被検体内の血流を測定する流速計算部と、血流を表示する表示部とを具備し、第1の構成では、複数の素子毎に超音波パルスの送受信を行ない、素子の正面の頭蓋骨の厚みを計測する手段と、頭蓋骨の厚みに基づいて、素子毎に頭蓋骨を透過する超音波強度が最大となる送信周波数を選択する手段と、選択された送信周波数の超音波パルスを超音波送受波器から頭蓋骨の内部に照射する手段とを有し、また、第2の構成では、複数の素子毎に超音波パルスの送受信を行ない、素子の正面の頭蓋骨の超音波透過率の周波数特性を測定する手段と、頭蓋骨を透過する超音波強度が最大となる送信周波数を選択する手段と、選択された送信周波数を超音波送受波器から頭蓋骨の内部に照射する手段とを有する。
【0012】
さらに、上記の第1及び第2の構成において、頭蓋骨の厚みに基づいて、素子毎の送信波形の振幅を制御する手段を有し、頭蓋骨の透過率分布と素子毎の送信振幅分布の積が、頭蓋骨を透過した後の振幅分布となるように、素子毎の送信振幅分布を決定する。
【0013】
【発明の実施の形態】
本発明では、頭蓋骨を切開せずに、超音波血流モニタリングの下で超音波照射によるtPAの血栓溶解効果の増強をもたらすことが可能な超音波装置を提供する。複数の素子からなる超音波送受波器を備え、脳内のtPAの効果を増強させる超音波照射と、治療の効果の血流撮像によるモニタリングとを交互に繰り返す超音波撮像装置(経頭蓋骨超音波撮像装置)であって、予め超音波送受波器を構成する各素子の正面の頭蓋骨の厚さを超音波で測定し、各素子毎に透過率極大となる周波数を求めるか、もしくは、直接超音波によって各素子正面の頭蓋骨の透過率極大となる周波数を求めることによって、tPAの治療効果の増強を最適化することができる。
【0014】
以下、本発明の実施例を、図面を参照して詳細に説明する。
【0015】
本発明では、経頭蓋骨超音波ドップラによるモニタリングにおける超音波照射と、tPAの血栓溶解効果を促進する超音波照射とにおいて、同じ周波数帯域の超音波を使う。そのために、板間層の有る場合と、ない場合の、超音波の透過率の周波数依存性をFDTD法(時間分解有限要素法)を使ってシミュレーションを行なった。
【0016】
図2は、本発明により得られた、頭蓋骨の超音波透過率の周波数特性を示す図である。図2では、板間層の有る場合の超音波の透過強度曲線40、板間層のない場合の超音波の透過強度曲線41を示している。図2に示す結果から、板間層の有る場合は、周波数が低いほど透過率が高いが、板間層の無い部分は1MHz近傍、2MHz近傍、3MHz近傍に透過率の極大点があることがわかる。この板間層が無い場所を選び、かつ極大点にあたる周波数を用いることで、経頭蓋骨トップラモニタリング用の超音波送受信器の周波数帯域内(通常は2MHzから5MHz)で、tPAの効果促進用の超音波も送波することが可能となる。
【0017】
この極大点は、波長/2の奇数倍の共振点に相当するので、骨の厚さが異なると透過率最大の周波数が異なる。図1に示す様に、送波焦点22に対して超音波の送受信を行なう場合、超音波トランスデューサの素子毎にその正面の骨の厚みが異なるため、素子毎に最適な周波数を調節する必要がある。
【0018】
以下、この素子毎に周波数を最適化した治療送波を実現するための第1の実施例の装置について説明する。
【0019】
図3は、本発明の第1の実施例の装置構成を示す図であり、図4は、本発明の第1の実施例の装置における操作(処理)を示すフロー図である。
【0020】
まず、図3に図示しない被検体に対して、複数の超音波素子から構成される超音波送受波器1を、図1に示す頭蓋骨20の上から超音波の通りの最も良い場所を探して、その場所に固定する。この場所を探すのは、Bモード像、もしくは、ドップラ像を観測しながら、超音波送受波器1の場所を変えることで探すことが出来る。
【0021】
超音波送受波器1を頭蓋骨20に固定した後、各素子毎にAモード撮像(図4に示すAモード撮像工程100)を行なうことで、各素子の正面での骨の厚さを測定する。制御系2の制御下で、骨厚み計測部3から、送受波切替スイッチ5(素子選択スイッチも兼ねる)によって選択される超音波送受波器1の中の1素子にパルス出力を送り、被検体内での反射信号を送受波切替スイッチ5を介して、骨厚み計測部3に再び戻し、反射信号を計測する。
【0022】
この時、最初の大きな反射信号は、超音波送受波器1に設けられた音響レンズと頭蓋骨表面からの反射信号であり、2番目の反射信号は、頭蓋骨の裏側からの反射であるので、その時間差から、この素子正面の頭蓋骨の厚みが測定出来る(図4の頭蓋骨厚み計測工程101)。骨の音速は厳密には個人差があるが、凡そ3300m/s程度であるので、この値から、半波長の奇数倍の共振周波数、即ち、超音波の透過率の極大点を求めることが出来る。この透過率の極大点は複数あり得るが、その中で、超音波送受波器1の有効な周波数帯域内で、最も周波数の低いものを選べば良い。何故なら、生体内の超音波減衰は周波数が高い程、減衰率が大きくなり、減衰分は熱に変わってしまう。脳においては、過度な温度上昇は厳禁であるから、血栓溶解用には、低い周波数を選んだ方が良い。この操作を各素子毎に繰り返す。この結果から、図4に示す治療周波数設定工程102で、治療モード時の各素子の超音波周波数が決定する。
【0023】
次に、従来公知のカラーフロー画像撮像(血流画像撮像)工程103の操作を行なう。これは制御系2の制御の下で、送波ビームフォーマ4から、送受波切替スイッチ5を介して、被検体に超音波パルスが送波され、被検体内での反射、散乱信号が先述とは逆の経路で超音波送受波器1と送受切替スイッチ5とを介して、受波ビームフォーマ11に入力される。受波ビームフォーマ11では、所定の焦点位置の信号を最大にするように素子毎の遅延時間を調整して加算する。この受波ビームフォーマ11の出力を検波器12で直交検波し、MTIフィルタ13と自己相関演算部14、流速、分散計算部15によって、被検体内の場所毎の流速が表示部16によって表示される。この血流画像撮像工程103を一定時間行なうと、治療超音波照射工程104に切り替わる。
【0024】
なお、この以前にオペレータにより患者の体内にtPAが投与されているものとする。治療超音波照射工程104においては、制御系2から骨厚み計算部3の出力によって、素子毎に最適な(透過率最大となる)周波数の送波信号が送波ビームフォーマ4から、送受波切替スイッチ5、超音波送受波器1を介して、被検体内に送波される。この治療超音波照射工程104を一定時間繰り返した後、再び、血流画像撮像工程103に戻り、治療効果を確認したあと、効果が不充分であれば、再び、治療超音波照射工程104によって治療超音波照射が行なわれる。血流画像撮像工程103で治療効果を充分と確認された場合、治療超音波照射は終了する(治療終了判定工程105)。
【0025】
この、血流画像撮像工程103の時間と治療超音波照射工程104の時間は、予め秒単位でデフォルトの値を設定しておいても良いし、オペレータが治療前にユーザインターフェース17から入力して、治療中にも適宜変更出来るようにしておいても良い。
【0026】
なお、このように素子毎に周波数を変えると、ビーム形状に影響を与えるが、治療超音波照射は、ビームを最大限に絞る必要は無いので、実施例1の方法では問題とならない。また、骨厚み計測部3から骨厚み計測用のパルス信号を送ると上記では説明したが、同じ思想に基づいて、パルス信号は送波ビームフォーマから1素子分の信号のみを送波しても効果は同じである。
【0027】
また、この方法で骨の厚みがわかると、血流像撮像にも、その効果を使うことが出来る。骨の音速は上記のように、約3300m/sであり、生体の音速の2倍以上あるため、骨に対し斜め入射の超音波は骨の前後の界面で屈折を起こす。これはフォーカスのぼけになるので、感度の低下を引き起こし、血流像、Bモード像を劣化させる大きな要因となる。これを防ぐには屈折の効果を入れたフォーカス演算を行なえば良いのであり、上記の厚みの計測によって、可能になる。屈折を直接計算しない方法としては、公知の適応像再生技術があるが、骨の厚みがわかっていると、適応像再生の第1近似値として、その出発点に用いることが可能となり、適応像再生の精度もしくは演算速度の高速化に寄与することが出来る。
【0028】
図5は、本発明の第2の実施例の装置構成を示す図であり、図6は、本発明の第2の実施例の装置における操作〈処理〉を示すフロー図である。
【0029】
第1の実施例では骨厚み計測部3で、Aモードと同じように信号を送受波して、反射パルス間隔から、骨の厚さが測定出来るが、パルス強度比から骨伝播時の透過率を測定することも可能である。第2の実施例では、透過率の周波数依存性を直接測定し、素子毎の最適周波数を選択する。即ち、第2の実施例の装置の構成は、第1の実施例の装置の構成のうち、骨厚み計測部3を、透過率測定部8と周波数決定部9で置き換えた構成とする。また、図4に示すAモード撮像工程100に代えて、図6では、透過率計測工程108を実行する。
【0030】
透過率測定部8では、超音波送受波器の感度の範囲内で送信パルスの中心周波数を掃引し、周波数決定部9で透過率最大の周波数を選ぶ。透過率の極大点が複数有る場合には、第1の実施例と同じく、脳内の温度上昇のことを考えて、最も周波数の低いものを選ぶ。この周波数が決まった後は、図5、図6に示す様に第1の実施例と同様な方法によって、治療とその効果のモニタリングを交互に行なうことが出来る。
【0031】
なお、透過率がわかると、超音波送受波器1の送信口径内の素子毎の振幅をも最適化することが可能となる。温度上昇を防ぐには、透過率の低い骨に向かい合う素子の送信エネルギーは減らし、透過率の大きい骨に向かい合う素子の送信エネルギーを増やすことで、頭蓋骨近傍の余分な温度上昇は抑えることが可能となる。
【0032】
一方でビーム形状を最適化したい場合は、図7に示す方法が有効である。
【0033】
図7は、本発明の第2の実施例による装置において、素子配列位置に関する、送信振幅分布33と、頭蓋骨を透過した後の送信振幅分布31、頭蓋骨の透過率の逆数の分布32の相互の関係を模式的に表わす図である。
【0034】
超音波送受波器1の素子の配列に沿った方向で、頭蓋骨を透過した後の超音波の振幅分布を、従来公知の超音波送受波器上での素子毎のアポタイゼーションと同じような形状になるように制御することで、超音波のビーム形状が頭蓋骨の透過によって劣化する効果を最小限にすることが可能となる。即ち、図7に示す、頭蓋骨の透過率の逆数の分布32と素子毎の送信振幅分布33の積が、頭蓋骨を透過した後の振幅分布31となるように、素子毎の送信振幅分布を決定すれば良い。いずれにせよ、頭蓋骨の透過率がわかることで、超音波の送信方法の指針に沿った方法、即ち、温度上昇の制御を優先するのか、ビーム形状を優先するのかというユーザのニーズに応じることが可能となる。
【0035】
本発明は、上記にある特定の実施の形態に限定されるものでなく、その技術思想の範囲を逸脱しない範囲で様々な変形が可能である。
【0036】
以上のように、本発明によって、経頭蓋骨で、tPAの効果増強のための超音波を被検体頭部の超音波送受波用の音響窓に最適化して照射する手段と、この血栓溶解効果をモニタリングする手段を兼ね備えることが可能となる。また、脳内及び頭蓋骨近傍での過度な温度上昇の防止が可能となる。
【0037】
本発明の超音波装置では、頭蓋骨の限られた音響窓を使って、経頭蓋骨超音波ドップラによるモニタリングと、超音波によるtPAの血栓溶解効果を促進する超音波照射を同じ周波数帯域の超音波を使用して実行できる。
【0038】
【発明の効果】
本発明によれば、経頭蓋骨超音波ドップラによるモニタリングにおける超音波照射と、tPAの血栓溶解効果を促進する超音波照射とにおいて、同じ周波数帯域の超音波を使うこと可能とする超音波装置を提供でき、超音波血流モニタリングの下で超音波照射によるtPAの血栓溶解効果の増強をもたらすことが可能な超音波装置を提供できる。
【図面の簡単な説明】
【図1】本発明において、超音波の送受波を行なう頭蓋骨のこめかみ周辺の断面と、頭蓋骨に対する超音波トランスデューサの素子列を示す図。
【図2】本発明の検討により得られた、頭蓋骨の超音波透過率の周波数特性を示す図。
【図3】本発明の第1の実施例の装置構成を示す図。
【図4】本発明の第1の実施例の装置における処理を示すフロー図。
【図5】本発明の第2の実施例の装置構成を示す図。
【図6】本発明の第2の実施例の装置における処理を示すフロー図。
【図7】本発明の第2の実施例において、素子配列位置に関する、送信振幅分布と、頭蓋骨を透過した後の送信振幅分布、頭蓋骨の透過率の逆数の分布の相互の関係を模式的に表わす図。
【符号の説明】
1…超音波送受波器、2…制御系、3…骨厚み計測部、4…送波ビームフォーマ、5…送受波切替スイッチ、8…透過率測定部、9…周波数決定部、11…受波ビームフォーマ、12…検波器、13…MTIフィルタ、14…自己相関演算器、15…流速、分散計算部、16…表示部、17…ユーザインターフェース、20…頭蓋骨、21…板間層、22…送波焦点、31…素子配列位置に関する頭蓋骨を透過した後の送信振幅分布、32…素子配列位置に関する頭蓋骨の透過率の逆数の分布、33…素子配列位置に関する送信振幅分布、40…板間層の有る場合の超音波の透過強度曲線、41…板間層のない場合の超音波の透過強度曲線、100…Aモード撮像工程、101…頭蓋骨厚み計測工程、102…治療周波数設定工程、103…血流画像撮像工程、104…治療超音波照射工程、105…治療終了判定、108…透過率計測工程。
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an ultrasonic imaging apparatus that captures an image of a subject using ultrasonic waves, an ultrasonic apparatus including a thrombus lysis apparatus using ultrasonic waves, and the like.
[0002]
[Prior art]
Transcranial ultrasonic Doppler measurement has already been established as a means for easily observing blood flow in the brain. It has also been proposed that transcranial ultrasonic Doppler measurement is performed during thrombolysis treatment using tPA (tissue plasminogen activator) (for example, see Non-Patent Document 1). The ultrasonic wave for Doppler measurement uses a frequency of about 2 MHz in consideration of resolution and attenuation.
[0003]
Regarding the effect of promoting the dissolution of thrombus by application of ultrasonic waves, a frequency of about 500 kHz is considered desirable from the effects of cavitation and temperature rise (see Non-Patent Document 2, for example).
[0004]
However, as described above, in order to use a relatively low frequency of about 500 kHz for treatment and a relatively high frequency of about 2 MHz for Doppler measurement, are both provided with separate transducers (for example, Patent Document 1)? 2), or by making the frequency of the monitoring ultrasonic wave an odd multiple of the frequency of the therapeutic ultrasonic wave, it is necessary to perform two roles with one transducer (see, for example, Patent Document 3).
[0005]
[Non-Patent Document 1]
AVAlexander, et al., “High Rate Complete Recanalization and Dramatic Clinical Recovery During tPA Infusion When Continuous ly Monitored With 2-MHz Transcranial Doppler Monitoring”, Stroke, 2002, vol.31, p.610-614
[Non-Patent Document 2]
T. Ishibashi, et al., “Can Transcranial Ultrasonication Increa se Recanalization Flow With Tissue Plasminogen Activator?”, Stroke, 2002, vol. 33, p.1399-1404
[Patent Document 1]
Japanese Patent Laid-Open No. 5-220152 [Patent Document 2]
JP 2001-327495 A [Patent Document 3]
JP-A-6-269448 [0006]
[Problems to be solved by the invention]
FIG. 1 is a diagram showing a cross section around a temple of a skull that transmits and receives ultrasonic waves and an element array of an ultrasonic transducer (ultrasonic transducer) 1 for the skull. The most part of the skull 20 has a structure in which a perforated interlaminar layer 21 is sandwiched between them as shown on both sides of FIG. 1, and the interlaminar layer 21 has a large attenuation of ultrasonic waves. It has been known. On the other hand, the temple portion has no interlamellar layer 21 or is very thin, so that it is known that the attenuation of the ultrasonic wave is less than that of the portion with the interlaminar layer 21, and the inside of the skull is imaged with ultrasonic waves. Or it is used as an acoustic window for treatment.
[0007]
However, since the size of the acoustic window area through which ultrasonic waves pass relatively well is limited to a few cm square, separate transducers are used side by side for monitoring and treatment in this narrow area. It has the problem that it is difficult.
[0008]
On the other hand, a single transducer serves both for monitoring and for treatment because the vibration of the transducer is actually coupled with a transverse mode in addition to the thickness resonance, and the acoustic matching layer When this is taken into consideration, there is a problem that designing to optimize for two frequencies is extremely difficult.
[0009]
An object of the present invention is to provide an ultrasonic device that can use ultrasonic waves in the same frequency band for ultrasonic irradiation in monitoring by transcranial ultrasonic Doppler and ultrasonic irradiation that promotes the thrombolytic effect of tPA. Accordingly, an object of the present invention is to provide an ultrasonic device capable of enhancing the thrombolytic effect of tPA by ultrasonic irradiation under ultrasonic blood flow monitoring.
[0010]
[Means for Solving the Problems]
In order to achieve the above object, in the present invention, a transducer for transmitting / receiving ultrasonic waves to a subject, a plurality of electric ultrasonic transducer elements (hereinafter referred to as elements) constituting the transducer, and a transducer are connected. An ultrasonic device (transcranial ultrasonic imaging device) that includes a transmitting beamformer and a receiving beamformer and capable of imaging a blood flow image, and transmitting and receiving ultrasonic pulses to determine the thickness distribution of the skull A means for measuring is provided, and a means for selecting a transmission frequency at which the transmittance is maximized for each element based on the thickness distribution is provided to optimize the enhancement of the effect of the thrombus dissolving agent by ultrasound.
[0011]
The ultrasonic apparatus of the present invention includes a plurality of electric ultrasonic transducers, an ultrasonic transducer for transmitting / receiving ultrasonic pulses to / from a subject, and a transmission / reception for switching between transmission and reception of ultrasonic waves to the element. A switch beam, a transmission beamformer connected to the transmission / reception wave changeover switch for controlling the transmission focal position of the ultrasonic wave in the subject, a reception beamformer for controlling the reception focal position in the subject, and reception A detector that receives the output of the beamformer, a flow velocity calculation unit that measures the blood flow in the subject from the output of the detector, and a display unit that displays the blood flow. The device transmits and receives ultrasonic pulses for each element, and measures the thickness of the skull in front of the element, and selects the transmission frequency that maximizes the intensity of ultrasonic waves that pass through the skull for each element, based on the thickness of the skull. Means and selected transmission Means for irradiating the inside of the skull with an ultrasonic pulse of a wave number from the ultrasonic transducer, and in the second configuration, the ultrasonic pulse is transmitted and received for each of a plurality of elements, and the skull in front of the elements Means for measuring the frequency characteristics of the ultrasound transmission rate, means for selecting the transmission frequency that maximizes the intensity of the ultrasound transmitted through the skull, and irradiating the selected transmission frequency to the inside of the skull from the ultrasonic transducer Means.
[0012]
Further, in the first and second configurations described above, there is provided means for controlling the amplitude of the transmission waveform for each element based on the thickness of the skull, and the product of the transmittance distribution of the skull and the transmission amplitude distribution for each element is The transmission amplitude distribution for each element is determined so that the amplitude distribution after passing through the skull is obtained.
[0013]
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides an ultrasonic device capable of enhancing the thrombolytic effect of tPA by ultrasonic irradiation under ultrasonic blood flow monitoring without incising the skull. An ultrasonic imaging device (transcranial ultrasonic wave) that includes an ultrasonic transducer composed of a plurality of elements and alternately repeats ultrasonic irradiation for enhancing the effect of tPA in the brain and monitoring of blood flow imaging of the effect of treatment. An imaging device) that measures the thickness of the skull in front of each element constituting the ultrasonic transducer with ultrasonic waves in advance and determines the frequency at which the transmittance is maximized for each element, or directly By obtaining the frequency at which the transmittance of the skull in front of each element is maximized by sound waves, the enhancement of the therapeutic effect of tPA can be optimized.
[0014]
Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
[0015]
In the present invention, ultrasonic waves in the same frequency band are used for ultrasonic irradiation in monitoring by transcranial ultrasonic Doppler and ultrasonic irradiation for promoting the thrombolytic effect of tPA. For this purpose, the frequency dependence of the transmittance of the ultrasonic wave with and without the interlaminar layer was simulated using the FDTD method (time-resolved finite element method).
[0016]
FIG. 2 is a diagram showing the frequency characteristics of the ultrasonic transmittance of the skull obtained by the present invention. FIG. 2 shows an ultrasonic transmission intensity curve 40 with an inter-plate layer and an ultrasonic transmission intensity curve 41 without an inter-plate layer. From the results shown in FIG. 2, in the case where there is an interlaminar layer, the lower the frequency, the higher the transmissivity, but the portion without the interlaminar layer may have a maximum transmittance near 1 MHz, 2 MHz, and 3 MHz. Recognize. By selecting a place where there is no interlaminar layer and using a frequency corresponding to the maximum point, it is possible to promote the effect of tPA within the frequency band (usually 2 MHz to 5 MHz) of the ultrasonic transceiver for transcranial topola monitoring. Ultrasonic waves can also be transmitted.
[0017]
Since this maximum point corresponds to a resonance point that is an odd multiple of wavelength / 2, the frequency with the maximum transmittance varies with the thickness of the bone. As shown in FIG. 1, when transmitting / receiving ultrasonic waves to / from the transmission focal point 22, the thickness of the bone on the front surface is different for each element of the ultrasonic transducer, so it is necessary to adjust the optimum frequency for each element. is there.
[0018]
Hereinafter, the apparatus of the first embodiment for realizing therapeutic transmission with the frequency optimized for each element will be described.
[0019]
FIG. 3 is a diagram showing an apparatus configuration of the first embodiment of the present invention, and FIG. 4 is a flowchart showing operations (processes) in the apparatus of the first embodiment of the present invention.
[0020]
First, with respect to a subject not shown in FIG. 3, the ultrasonic transducer 1 composed of a plurality of ultrasonic elements is searched from the top of the skull 20 shown in FIG. , Fix in place. This location can be found by changing the location of the ultrasonic transducer 1 while observing a B-mode image or a Doppler image.
[0021]
After the ultrasonic transducer 1 is fixed to the skull 20, A-mode imaging (A-mode imaging step 100 shown in FIG. 4) is performed for each element, thereby measuring the bone thickness in front of each element. . Under the control of the control system 2, a pulse output is sent from the bone thickness measuring unit 3 to one element in the ultrasonic transducer 1 selected by the transmission / reception wave changeover switch 5 (also serving as an element selection switch) The reflected signal is returned to the bone thickness measuring unit 3 again via the transmission / reception wave changeover switch 5, and the reflected signal is measured.
[0022]
At this time, the first large reflected signal is a reflected signal from the acoustic lens provided on the ultrasonic transducer 1 and the skull surface, and the second reflected signal is reflected from the back side of the skull. From the time difference, the thickness of the skull in front of the element can be measured (skull thickness measuring step 101 in FIG. 4). Strictly speaking, the speed of sound of the bone varies from person to person, but is about 3300 m / s. From this value, the resonance frequency that is an odd multiple of a half wavelength, that is, the maximum point of the transmittance of ultrasonic waves can be obtained. . There may be a plurality of maximum points of the transmittance, and among them, the one having the lowest frequency within the effective frequency band of the ultrasonic transducer 1 may be selected. This is because the attenuation rate of ultrasonic attenuation in a living body increases as the frequency increases, and the attenuation is changed to heat. In the brain, excessive temperature rise is strictly prohibited, so it is better to choose a lower frequency for thrombolysis. This operation is repeated for each element. From this result, in the treatment frequency setting step 102 shown in FIG. 4, the ultrasonic frequency of each element in the treatment mode is determined.
[0023]
Next, an operation of a conventionally known color flow image capturing (blood flow image capturing) step 103 is performed. This is because, under the control of the control system 2, an ultrasonic pulse is transmitted from the transmission beam former 4 to the subject via the transmission / reception wave changing switch 5, and reflection and scattering signals in the subject are as described above. Is input to the receiving beamformer 11 via the ultrasonic transducer 1 and the transmission / reception change-over switch 5 in the reverse path. The receiving beam former 11 adjusts and adds the delay time for each element so as to maximize the signal at a predetermined focal position. The detector 12 performs quadrature detection on the output of the receiving beam former 11, and the MTI filter 13, the autocorrelation calculator 14, the flow velocity / dispersion calculator 15 display the flow velocity at each location in the subject on the display 16. The When this blood flow image capturing step 103 is performed for a certain time, the treatment ultrasonic wave irradiation step 104 is switched.
[0024]
It is assumed that tPA has been administered into the patient's body by the operator before this. In the therapeutic ultrasonic wave irradiation step 104, a transmission signal having an optimal frequency (maximum transmittance) is transmitted from the transmission beamformer 4 to the transmission / reception switching unit for each element based on the output of the bone thickness calculation unit 3 from the control system 2. The wave is transmitted into the subject via the switch 5 and the ultrasonic transducer 1. After repeating this therapeutic ultrasound irradiation step 104 for a certain time, the process returns to the blood flow image capturing step 103 again, and after confirming the therapeutic effect, if the effect is insufficient, the therapeutic ultrasonic irradiation step 104 again treats. Ultrasonic irradiation is performed. When it is confirmed that the therapeutic effect is sufficient in the blood flow image capturing step 103, the therapeutic ultrasonic wave irradiation ends (treatment end determination step 105).
[0025]
The time of the blood flow image capturing step 103 and the time of the treatment ultrasound irradiation step 104 may be set in advance as default values in units of seconds, or may be input from the user interface 17 by the operator before the treatment. It may be possible to change it appropriately during treatment.
[0026]
If the frequency is changed for each element in this way, the beam shape is affected. However, the treatment ultrasonic wave irradiation does not need to squeeze the beam to the maximum, so that there is no problem in the method of the first embodiment. Although the above description has been made when a bone thickness measurement pulse signal is sent from the bone thickness measurement unit 3, based on the same idea, the pulse signal may be transmitted only from the transmission beamformer for one element. The effect is the same.
[0027]
If the thickness of the bone is known by this method, the effect can also be used for blood flow imaging. As described above, the sound velocity of the bone is about 3300 m / s, which is more than twice the sound velocity of the living body. Therefore, the ultrasonic wave obliquely incident on the bone is refracted at the front and back interfaces of the bone. This causes blurring of the focus, causing a decrease in sensitivity and a major factor that degrades the blood flow image and the B-mode image. In order to prevent this, it is only necessary to perform a focus calculation with an effect of refraction, and this can be achieved by measuring the thickness. As a method of not directly calculating refraction, there is a known adaptive image reproduction technique. However, if the thickness of the bone is known, it can be used as a first approximation value of adaptive image reproduction as a starting point, and the adaptive image is reproduced. This can contribute to the improvement of reproduction accuracy or calculation speed.
[0028]
FIG. 5 is a diagram showing an apparatus configuration of the second embodiment of the present invention, and FIG. 6 is a flowchart showing an operation <process> in the apparatus of the second embodiment of the present invention.
[0029]
In the first embodiment, the bone thickness measuring unit 3 can transmit and receive a signal in the same manner as in the A mode, and the bone thickness can be measured from the reflected pulse interval. Can also be measured. In the second embodiment, the frequency dependency of the transmittance is directly measured, and the optimum frequency for each element is selected. That is, the configuration of the apparatus of the second embodiment is a configuration in which the bone thickness measuring unit 3 is replaced with the transmittance measuring unit 8 and the frequency determining unit 9 in the configuration of the apparatus of the first example. Further, in place of the A-mode imaging step 100 shown in FIG. 4, a transmittance measuring step 108 is executed in FIG.
[0030]
The transmittance measuring unit 8 sweeps the center frequency of the transmission pulse within the sensitivity range of the ultrasonic transducer, and the frequency determining unit 9 selects the frequency with the maximum transmittance. When there are a plurality of maximum points of transmittance, the one with the lowest frequency is selected in consideration of the temperature rise in the brain as in the first embodiment. After this frequency is determined, treatment and monitoring of its effect can be performed alternately by the same method as in the first embodiment as shown in FIGS.
[0031]
If the transmittance is known, the amplitude of each element within the transmission aperture of the ultrasonic transducer 1 can be optimized. In order to prevent the temperature rise, the transmission energy of the element facing the bone with low transmittance is reduced, and the transmission energy of the element facing the bone with high transmittance is increased, so that it is possible to suppress the excessive temperature rise near the skull. Become.
[0032]
On the other hand, when it is desired to optimize the beam shape, the method shown in FIG. 7 is effective.
[0033]
FIG. 7 shows a transmission amplitude distribution 33, a transmission amplitude distribution 31 after passing through the skull, and a reciprocal distribution 32 of the transmittance of the skull in the device according to the second embodiment of the present invention. It is a figure showing a relation typically.
[0034]
The amplitude distribution of the ultrasonic wave after passing through the skull in the direction along the arrangement of the elements of the ultrasonic transducer 1 is similar to the apodization for each element on the conventionally known ultrasonic transducer. By controlling so as to have a shape, it is possible to minimize the effect that the ultrasonic beam shape deteriorates due to the transmission of the skull. That is, the transmission amplitude distribution for each element is determined so that the product of the reciprocal distribution 32 of the skull transmittance and the transmission amplitude distribution 33 for each element shown in FIG. 7 becomes the amplitude distribution 31 after passing through the skull. Just do it. In any case, by knowing the transmittance of the skull, it is possible to meet the user's needs whether to give priority to the control of the temperature rise or the beam shape according to the guideline of the ultrasonic transmission method. It becomes possible.
[0035]
The present invention is not limited to the specific embodiments described above, and various modifications can be made without departing from the scope of the technical idea thereof.
[0036]
As described above, according to the present invention, the means for irradiating the transcranial bone with the ultrasonic wave for enhancing the effect of tPA by optimizing the acoustic window for ultrasonic wave transmission / reception of the subject head, and the thrombolytic effect are obtained. It is possible to have a means for monitoring. Further, it is possible to prevent an excessive temperature rise in the brain and in the vicinity of the skull.
[0037]
In the ultrasonic device of the present invention, using a limited acoustic window of the skull, monitoring by transcranial ultrasonic Doppler and ultrasonic irradiation for promoting the thrombolytic effect of tPA by ultrasonic waves are performed using ultrasonic waves in the same frequency band. Can be used and executed.
[0038]
【The invention's effect】
According to the present invention, there is provided an ultrasonic apparatus capable of using ultrasonic waves in the same frequency band for ultrasonic irradiation in monitoring by transcranial ultrasonic Doppler and ultrasonic irradiation for promoting the thrombolytic effect of tPA. And an ultrasonic device capable of enhancing the thrombolytic effect of tPA by ultrasonic irradiation under ultrasonic blood flow monitoring.
[Brief description of the drawings]
FIG. 1 is a diagram showing a cross section around a temple of a skull that transmits and receives ultrasonic waves in the present invention, and an element array of an ultrasonic transducer for the skull.
FIG. 2 is a diagram showing the frequency characteristics of the ultrasonic transmission rate of the skull obtained by the study of the present invention.
FIG. 3 is a diagram showing an apparatus configuration of a first embodiment of the present invention.
FIG. 4 is a flowchart showing processing in the apparatus of the first embodiment of the present invention.
FIG. 5 is a diagram showing a device configuration of a second embodiment of the present invention.
FIG. 6 is a flowchart showing processing in the apparatus of the second embodiment of the present invention.
FIG. 7 schematically shows the relationship between the transmission amplitude distribution, the transmission amplitude distribution after passing through the skull, and the inverse distribution of the transmittance of the skull in the second embodiment of the present invention. Figure representing.
[Explanation of symbols]
DESCRIPTION OF SYMBOLS 1 ... Ultrasonic transmitter / receiver, 2 ... Control system, 3 ... Bone thickness measurement part, 4 ... Transmission beam former, 5 ... Transmission / reception wave changeover switch, 8 ... Transmittance measurement part, 9 ... Frequency determination part, 11 ... Reception Wave beam former, 12 ... detector, 13 ... MTI filter, 14 ... autocorrelation calculator, 15 ... flow velocity, dispersion calculation unit, 16 ... display unit, 17 ... user interface, 20 ... skull, 21 ... interplate layer, 22 ... Transmission focal point, 31... Transmission amplitude distribution after passing through the skull with respect to the element arrangement position, 32... Distribution of reciprocal number of skull transmittance with respect to the element arrangement position, 33... Transmission amplitude distribution with respect to the element arrangement position, 40. Ultrasonic transmission intensity curve when there is a layer, 41 ... Ultrasonic transmission intensity curve when there is no interplate layer, 100 ... A-mode imaging step, 101 ... Skull thickness measurement step, 102 ... Treatment frequency setting step, 103 ... Flow imaging step, 104 ... treatment ultrasonic irradiation step, 105 ... end of treatment determination, 108 ... transmittance measurement step.

Claims (7)

複数の電気超音波変換素子からなり、被検体に対して、超音波パルスを送受信する超音波送受波器と、前記素子に対し超音波の送信と受信を切りかえる送受波切替スイッチと、前記送受波切替スイッチに接続し、前記被検体内での超音波の送信焦点位置を制御する送波ビームフォーマと、前記被検体内の受信焦点位置を制御する受波ビームフォーマと、前記受波ビームフォーマの出力を入力とする検波器と、前記検波器の出力から前記被検体内の血流を測定する流速計算部と、前記血流を表示する表示部と、前記複数の素子毎に超音波パルスの送受信を行ない、前記素子の正面の頭蓋骨の超音波透過率の周波数特性を測定する手段と、前記頭蓋骨を透過する超音波強度に基づいて送信周波数を選択する手段と、選択された前記送信周波数を前記超音波送受波器から前記頭蓋骨の内部に照射する手段とを有し、
前記送波ビームフォーマは、血栓溶解のための超音波と、血流計測のための超音波との送波を制御することを特徴とする超音波装置。
An ultrasonic transducer comprising a plurality of electric ultrasonic transducers, and transmitting / receiving ultrasonic pulses to / from a subject, a transmission / reception switching switch for switching between transmission and reception of ultrasonic waves to the element, and the transmission / reception A transmission beamformer connected to a changeover switch for controlling a transmission focal position of an ultrasonic wave in the subject, a reception beamformer for controlling a reception focal position in the subject, and a reception beamformer A detector that receives an output; a flow velocity calculation unit that measures blood flow in the subject from the output of the detector; a display unit that displays the blood flow; and an ultrasonic pulse for each of the plurality of elements. Means for transmitting and receiving, measuring the frequency characteristics of the ultrasound transmittance of the skull in front of the element, means for selecting a transmission frequency based on the intensity of ultrasound transmitted through the skull, and the selected transmission frequency in front And a means for irradiating the ultrasonic transducer inside the skull,
The ultrasonic beam former controls an ultrasonic wave for thrombolysis and ultrasonic wave for blood flow measurement.
請求項1に記載の超音波装置において、前記送波ビームフォーマは、前記頭蓋骨の厚みに基づいて、前記素子毎の送信波形の振幅を制御することを特徴とする超音波装置。  The ultrasonic apparatus according to claim 1, wherein the transmission beamformer controls an amplitude of a transmission waveform for each element based on a thickness of the skull. 請求項1に記載の超音波装置において、前記送波ビームフォーマは、血栓溶解のための超音波と、血流計測のための超音波との送波を交互に繰り返すことを特徴とする超音波装置。  2. The ultrasonic device according to claim 1, wherein the transmission beamformer alternately repeats transmission of ultrasonic waves for thrombolysis and ultrasonic waves for blood flow measurement. apparatus. 請求項1乃至3のいずれかに記載の超音波装置において、前記選択する手段は、前記透過する超音波強度の選択候補となる送信周波数が複数ある場合には、最も周波数の低いものを選択することを特徴とする超音波装置。  4. The ultrasonic device according to claim 1, wherein when there are a plurality of transmission frequencies that are candidates for selection of the transmitted ultrasonic intensity, the selecting unit selects the lowest frequency. 5. An ultrasonic device characterized by that. 請求項1乃至4のいずれかに記載の超音波装置において、前記送波ビームフォーマは、同じ周波数帯域の超音波を使用して、前記血栓溶解のための超音波と、前記血流計測のための超音波を行うことを特徴とする超音波装置。  5. The ultrasonic device according to claim 1, wherein the transmission beamformer uses ultrasonic waves in the same frequency band to measure the ultrasonic waves for thrombolysis and the blood flow measurement. An ultrasonic device characterized by performing ultrasonic waves. 請求項1乃至5のいずれかに記載の超音波装置において、前記送波ビームフォーマは、前記血栓溶解のための超音波と、前記血流計測のための超音波、それぞれにおいて前記素子毎の送信波形が異なるように制御を行うことを特徴とする超音波装置。  6. The ultrasonic apparatus according to claim 1, wherein the transmission beamformer transmits the ultrasonic wave for thrombolysis and the ultrasonic wave for blood flow measurement for each element. An ultrasonic apparatus, wherein control is performed so that waveforms are different. 請求項1乃至6のいずれかに記載の超音波装置において、前記測定する手段は、パルス強度比からの骨伝播時の透過率を測定することを特徴とする超音波装置。7. The ultrasonic apparatus according to claim 1, wherein the measuring means measures a transmittance at the time of bone propagation from a pulse intensity ratio.
JP2002320789A 2002-11-05 2002-11-05 Ultrasonic device Expired - Fee Related JP4320157B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002320789A JP4320157B2 (en) 2002-11-05 2002-11-05 Ultrasonic device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002320789A JP4320157B2 (en) 2002-11-05 2002-11-05 Ultrasonic device

Publications (2)

Publication Number Publication Date
JP2004154205A JP2004154205A (en) 2004-06-03
JP4320157B2 true JP4320157B2 (en) 2009-08-26

Family

ID=32801530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002320789A Expired - Fee Related JP4320157B2 (en) 2002-11-05 2002-11-05 Ultrasonic device

Country Status (1)

Country Link
JP (1) JP4320157B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186574B2 (en) 2017-11-09 2025-01-07 West Affum Holdings Dac WCD monitor supporting serviceability and reprocessing

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4401354B2 (en) 2003-05-19 2010-01-20 株式会社日立製作所 Ultrasonic therapy device
US7828754B2 (en) 2004-06-21 2010-11-09 Hiroshi Furuhata Ultrasonic cerebral infarction therapeutic apparatus
US7921717B2 (en) 2005-01-03 2011-04-12 Siemens Medical Solutions Usa, Inc. Ultrasonic imaging system
JP2009025103A (en) * 2007-07-18 2009-02-05 Tokyo Electric Power Co Inc:The Reflection method
JP6300397B2 (en) * 2013-08-02 2018-03-28 国立大学法人九州大学 Ultrasonic therapy device
CN113117266B (en) * 2019-12-30 2023-02-28 重庆融海超声医学工程研究中心有限公司 Temperature monitoring equipment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186574B2 (en) 2017-11-09 2025-01-07 West Affum Holdings Dac WCD monitor supporting serviceability and reprocessing

Also Published As

Publication number Publication date
JP2004154205A (en) 2004-06-03

Similar Documents

Publication Publication Date Title
JP4551524B2 (en) Ultrasonic probe and ultrasonic diagnostic apparatus
US7753847B2 (en) Ultrasound vibrometry
US7785259B2 (en) Detection of motion in vibro-acoustography
JP4667733B2 (en) Method and apparatus for enhancing ultrasound contrast imaging using stepped chirp waveform
US5678554A (en) Ultrasound transducer for multiple focusing and method for manufacture thereof
US6984209B2 (en) Harmonic motion imaging
JP5514911B2 (en) Ultrasonic imaging device
CN103492855B (en) Ultrasonic vibrometry using unfocused ultrasound
CN113616245B (en) Imaging method and system based on multi-frequency ultrasonic transducer
US20030055337A1 (en) Dual-frequency ultrasonic array transducer and method of harmonic imaging
CN109730722B (en) Elastic imaging method based on focused ultrasonic acoustic vibration signal
CN101460094A (en) Multiple frequency Doppler ultrasound probe
CN103549977A (en) Transcranial Doppler plane annular phased array probe
WO2020006812A1 (en) Method and device for measuring mechanical property parameters of tissue
CN109745077B (en) A method for detecting elastic properties based on focused ultrasonic vibro-acoustic signals
JPS62502283A (en) Methods and equipment for ultrasound reflection-transmission imaging
JP4320157B2 (en) Ultrasonic device
JP4688262B2 (en) Ultrasonic diagnostic equipment
JP4263575B2 (en) Ultrasonic transmitter and ultrasonic apparatus using the same
KR101411099B1 (en) Method for generating mechanical waves by creating an interfacial acoustic radiation force
EP1815795B1 (en) Ultrasonographic device
JP4940048B2 (en) Ultrasonic imaging device
JP3502727B2 (en) Ultrasound imaging device
JP5325670B2 (en) Ultrasonic diagnostic equipment
Amador et al. Effects of phase aberration on acoustic radiation force-based shear wave generation

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20021226

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051025

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070328

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070328

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070328

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070328

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080916

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090127

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090512

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090601

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120605

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120605

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120605

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130605

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees